Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ROS1 Fusion Resistance Mechanisms

Jessica Lin

MD

🏢Massachusetts General Hospital🌐USA

Associate Professor of Medicine

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Jessica Lin is a thoracic oncologist who has led pivotal trials of repotrectinib for ROS1-positive NSCLC including patients with resistance to prior ROS1 inhibitors. Her research defines the landscape of ROS1 solvent front and compound mutations. She has contributed to understanding sequential therapy strategies for ROS1-rearranged tumors.

Share:

🧪Research Fields 研究领域

ROS1 fusions
Repotrectinib
Resistance mutations
NSCLC targeted therapy
Molecular oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Jessica Lin 的研究动态

Follow Jessica Lin's research updates

留下邮箱,当我们发布与 Jessica Lin(Massachusetts General Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment